CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
to evaluate the safety and efficacy of first-line chemo-immunotherapy combinations in participants with metastatic pancreatic ductal adenocarcinoma...
Phase 1
Philadelphia, Pennsylvania, United States and 5 other locations
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...
Phase 3
Philadelphia, Pennsylvania, United States of America and 53 other locations
The goal of this clinical trial is to determine clinical advantages for LP-300 in combination with carboplatin and pemetrexed in the never smoker pat...
Phase 2
Philadelphia, Pennsylvania, United States of America and 18 other locations
The purpose of this study is to test any good and bad effects of the study drug called PEGPH20. PEGPH20 alone is considered investigational. The Food...
Allentown, Pennsylvania, United States and 9 other locations
The purpose of this study is to combine standard radiation therapy with drugs that encourages the body's immune system against cancer cells and simul...
Phase 2
Philadelphia, Pennsylvania, United States and 4 other locations
as First-Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma...
Phase 2
Philadelphia, Pennsylvania, United States of America and 47 other locations
The main goal of this study is to look at the effectiveness and anti-tumor activity (preventing growth of the tumor) of the drugs niraparib and ipili...
Phase 2
Philadelphia, Pennsylvania, United States and 1 other location
participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSignatur...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States of America and 66 other locations
adenocarcinoma (GEA), biliary tract cancer (BTC), or colorectal cancer (CRC)....
Phase 2
Philadelphia, Pennsylvania, United States of America and 22 other locations
after complete surgical resection (R0) in participants with Stage I adenocarcinoma NSCLC who are ctDNA-positive, as determined by the Sponso...
Phase 3
Philadelphia, Pennsylvania, United States and 214 other locations
Clinical trials
Research sites
Resources
Legal